Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases. [electronic resource]
Producer: 20150619Description: 2034-43 p. digitalISSN:- 1098-1136
- Animals
- Calcium-Binding Proteins -- metabolism
- Cell Count
- Cells, Cultured
- Dopamine -- metabolism
- Electron Transport Complex I -- metabolism
- Enzyme Inhibitors -- pharmacology
- Glial Fibrillary Acidic Protein -- metabolism
- Mesencephalon -- cytology
- Microfilament Proteins -- metabolism
- Microglia -- drug effects
- NADPH Oxidases -- metabolism
- NADPH-Ferrihemoprotein Reductase -- metabolism
- Neurons -- drug effects
- Nitric Oxide Synthase Type II -- metabolism
- Nitrites -- metabolism
- Onium Compounds -- pharmacology
- Superoxides -- metabolism
- Thioredoxin-Disulfide Reductase -- metabolism
- Tyrosine 3-Monooxygenase -- metabolism
- Xanthine Oxidase -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.